Giant cell arteritis (GCA) is a granulomatous vasculitis affecting persons over 50 years of age. The inflammatory infiltrate, which is targeted at the aorta and its proximal branches, includes activated CD4' helper T cells, histiocytes, and giant cells. To investigate whether the genetic polymorphism of the HLA-DRB1 genes contributes to the local accumulation of activated T cells, we have analyzed both HLA-DRB1 alleles in a cohort of 42 patients with biopsy-proven GCA. The majority of patients (60%) expressed the B1 *0401 or B1*0404/8 variant of the HLA-DR4 haplotype, both of which also represent the major genetic factors underlying the disease association in RA. GCA patients negative for the disease-linked HLA-DR4 alleles were characterized by a nonrandom distribution of HLA-DRB1 alleles. Sequence comparison among the allelic products identified in the GCA cohort demonstrated heterogeneity for the sequence polymorphism of the third hypervariable region (HVR), but homology for the polymorphic residues within the HVR2 of the HLA-DRB1 gene. The GCA patients shared a sequence motif spanning amino acid positions 28-31 of the HLA-DR,81 chain. In the structural model for HLA-DR molecules, this sequence motif can be mapped to the antigen-binding site of the HLA complex, suggesting a crucial role of antigen selection and presentation in GCA. In contrast, the sequence polymorphism linked to RA has been mapped to the HVR3 of the HLA-DRB1 gene and translates into a distinct domain of the HLA-DR molecule, the a-helical loop surrounding the antigen-binding groove. A consecutive case series study demonstrated that GCA and RA rarely co-occurred, supporting the interpretation that distinct functional domains of the HLA-DR molecule are implicated in the pathomechanisms of these two autoimmune diseases. (J. Clin. Invest. 1992. 90:2355-2361 
Introduction
Giant cell arteritis (GCA)' is a clinicopathological syndrome characterized by a granulomatous vasculitis ofthe extracranial branches ofthe proximal aorta ( 1 ). In many populations GCA is the most common vasculitic syndrome in persons over 50 yr ofage and ifnot treated promptly may represent a life-threatening vascular disease (2, 3) . The pathogenesis of the disease is essentially unknown. Clues to the understanding of the underlying pathomechanisms have come from the analysis of the cellular infiltrate damaging the wall of the involved vessels. A granulomatous inflammatory reaction with dense infiltrates of mononuclear leukocytes, usually including multinucleated giant cells, is typical for GCA (4) . Immunohistochemical studies have demonstrated that CD4+ helper T lymphocytes represent the dominant cell population (5) . Subsequent studies of these cells have shown that markers of T cell activation are expressed locally, supporting the notion that a T helper celldriven immune response is the cause of the vascular damage. In general, T cells are activated when they specifically recognize a complex formed by a fragment of a foreign antigen and an autologous HLA molecule (6) . No disease causative antigen has been identified in GCA. The characteristic histological findings of the inflammatory infiltrate accumulating around the internal elastic lamina have led to speculations that degenerated elastic fibers represent the autoantigen initiating and perpetuating the chronic immune response. The frequent acute onset of clinical symptoms accompanied by an intense acute phase reaction has also raised questions of an infectious agent playing at least a precipitating role.
In this report, we have studied allelic HLA polymorphisms that are important in determining immunoresponsiveness to exogenous antigens. An association of the disease with the HLA-DR4 haplotype has been described but reports on the distribution of HLA haplotypes in GCA patients have not been conclusive (7-1 1 ). To address the question whether gene products ofthe HLA class II complex might contribute to GCA, we have analyzed the functionally most important locus, the HLA-DRB1 locus, in a cohort of patients with biopsy-proven GCA. Three allelic variants ofthe HLA-DRB 1 *04 family were found to be overrepresented among GCA patients. Interestingly, GCA is linked to the very same allelic variants as RA. However, despite the overrepresentation of HLA-DRB 1 *04 in GCA and RA, the risk to develop both diseases is low, suggesting that distinct pathomechanisms underlie the immune abnormalities in both diseases. More importantly, we found a sequence motif spanning the amino acid positions [28] [29] [30] [31] that is shared by all GCA patients and that is different from that found in RA. This sequence stretch translates into a polymorphic site in the antigen-binding groove of the HLA-DR molecule, suggesting a crucial role in the selection and presentation of antigen to T lymphocytes.
Methods
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Patients. 42 patients who were seen in the Division of Rheumatology, Mayo Clinic, between May 1990 and January 1992 were enrolled into the study. 22 patients were newly diagnosed, and 20 patients were diagnosed before 1991. All patients had characteristic histological findings on biopsy. 41 of the patients were Caucasian and 1 was Asian Indian. 32 patients were from a local geographic area. To assess the demographic and clinical characteristics of the study population, the files of all 42 patients were reviewed. Data for the following parameters were collected: age at onset of the disease; sex; presence of musculoskeletal pain confined to the shoulder and pelvic girdle, indicating symptoms of polymyalgia rheumatica (PMR); and permanent vision loss. To document permanent vision loss, atrophy of the optical nerve as diagnosed by an ophthalmologist was required. GCA patients diagnosed before 1989 were evaluated for relapses of the disease or requirement for longterm corticosteroid therapy. Patients were identified who required corticosteroid therapy for > 2 yr.
To identify patients who had biopsy-proven GCA as well asseropositive RA, we used a computerized search of the Mayo Clinic data base for the period 1976-1990. 835 patients carried the diagnosis ofbiopsyproven GCA. Within that cohort, 22 patients were diagnosed with polyarthritis. The charts of these 22 patients were reviewed to identify the underlying disease causing the polyarthritis. The diagnosis of polyarthritis secondary to GCA was verified in patients who were negative for rheumatoid factor and fulfilled the clinical and radiological characteristics described recently ( 12) . RA and systemic lupus erythematosus were diagnosed according to the criteria of the American College of Rheumatology ( 13, 14 42 patients with biopsyproven GCA were enrolled into this study. The group included 9 males and 33 females. Allele-specific amplification of genomic DNA was used to identify both HLA-DRB I alleles in each patient. As shown in Table I , the distribution of HLA-DRBl alleles among GCA patients was different from that in normals. HLA-DRB1 *04 was present in 59.5% of the patients. Three allelic variants, B 1 *0401, B 1 *0404, and B 1 *0408, were identified in the patient cohort. B 1 *0404 and *0408 are distinct only at position 86 (V --G) and were grouped together. Three of seven patients typed HLA-DRB 1 *0408. Interestingly, none of the HLA-DRB 1 *04 + patients used the B 1 *0402 and B 1 *0403 allele. These two alleles are rare in the normal population. The second most frequent allele was HLA-DRB1 *03. Overrepresentation ofHLA-DRB 1 *03, however, did not reach statistical significance. The overexpression of HLA-DRB 1 *04 within the GCA cohort was accompanied by a reduction of HLA-DRB1*01. A reduced frequency was also seen for HLA-DRB I * l1, B 1 *07, and B I * 15/ 16. An equal representation within patients and normals was characteristic for B1 *08 and B 1 * 13. We subsequently analyzed the role of allelic combinations in the patient group. Fig. 1 summarizes the haplotype combinations at the Bl locus for the 25 HLA-DRB1 *04+ patients. In Fig. 2 , both HLA-DRBl alleles of the 17 HLA-DRB 1 *04-patients are shown. The HLA-DRB 1 *04-patient subset was characterized by a nonrandom distribution of alleles. Three HLA-DRB 1 variants were overrepresented: HLA-DRB 1 *03, B 1 *08, and BI * 13. HLA-DRB 1 *03 was found in 8 of 17 patients compared with 11 of 48 DRB 1 *04 -controls (P = 0.06), DRB 1 *08 was found in 6 of 17 patients compared with 6 of 48 controls (P = 0.04). Only four patients were negative for all three alleles. These four patients shared the HLA-DRB 1* 15 / 16 haplotype. HLA-DRB 1 *01 and *07 were clearly underrepresented in HLA-DRB 1 *04-patients (5.8 vs. 27%, P = 0.06; and 5.8 vs. 29%, P = 0.04, respectively) ( Fig. 2) . The HLA-DRB 1 *0301 allele was not only frequently seen in non-DR4 patients, but was also preferentially expressed in combina- Table I demonstrate that the HLA-DRBI *0101 allele is not enriched in GCA patients. This allele is rather diminished, in particular, in the HLA-DRB1 *04-GCA population (Fig. 2) , indicating that the sequence polymorphism of the HVR3 found in RA is not relevant for the risk of GCA patients to develop the vasculitis. The genotyping for the HLA-DRB 1 genes in GCA revealed an overrepresentation of HLA-DRB 1*04 alleles but also a nonrandom spectrum of non-DRB 1 *04 haplotypes. This finding raised the possibility that a region of sequence homology integrated into HLA-DRB 1*04, but also into some of the DRB1 *04-gene products, was shared by GCA patients. To identify a common denominator among the GCA patients, we compared the sequence polymorphism of the HLA-DRB1 alleles B 1 *0301, BI * 1301 /2, and B 1 *0801 frequently found in DRB 1*04-GCA patients with B 1*0401 and *0404/8. The disease-associated alleles share a sequence motif encoded by the HVR2; in particular, the polymorphic amino acid positions 28, 30, and 31 are identical (Fig. 3) . The amino acid sequence motif DRYF, which was expressed by all 42 GCA patients, is not present in the HLA-DRB 1 alleles *01 and *07, which were found to be decreased in the GCA population. The recent resolution ofthe three-dimensional structure ofan HLA molecule has allowed correlation of polymorphic sites with functional regions ofthe molecule ( 18 ) . Human HLA-DR molecules are expressed on the cell surface as a heterodimer. #-pleated sheets encoded by the HVR1 and HVR2 ofthe a and / chain form the bottom of a groove that is surrounded by two a-helical formations building the walls of the cleft (Fig. 4) . There is overwhelming evidence that the groove represents the binding site for antigenic peptides that are embedded between the a-helical walls. The complex formed by the antigenic peptide bound in the groove of the HLA molecules represents the ligand for the T cell receptor and is required to initiate T cell activation. Thus, our data indicate that a polymorphic region cule is shared by patients who develop GCA (Fig. 4) .
Discussion
A lymphocytic infiltrate in the walls of medium-and largesized arteries is the characteristic finding in GCA (4, 5 (6) . Thus, HLA molecules are an absolute requirement for selection and binding of antigenic determinants and the subsequent triggering of the T cell receptor. The polymorphism of HLA-DR molecules is mainly determined by the highly polymorphic HLA-DRB I locus for which an estimated 80 alleles have been described (20) . Here, we report that the expression of HLA-DRB1 alleles by patients with GCA is nonrandom. 60% ofthe patients carried one ofthe closely related allelic variants, HLA-DRB1 *0401 and *0404/ 8. The difference between these three alleles is limited to a polymorphism in residue positions 71 and 86 of the B1 gene product. Two other allelic products ofthe HLA-DRB 1 *04 family, B 1 *0402 and *0403, were not identified within the patient population.
k Figure 4 . Mapping of the GCA-linked sequence motif to the antigen-binding site ofthe HLA-DR molecule. The HLA-DR sequence was modeled on the crystal structure of the HLA-A2 as described by Brown et al. ( 18 ) . Although an HLA-DR association of the disease has been reported, data have been controversial. Several studies have attempted to identify a GCA-associated haplotype (7-1 1 ). All available data used conventional techniques and could not distinguish among allelic variants of the DRB 1 *04 family. In all reports, the frequency of HLA-DR4 was increased, although the difference among the patient population and normal controls did not always reach statistical significance. Interestingly, the HLA-DR4 association of GCA is supported by differences in the incidence of the disease in distinct ethnic groups. An increased frequency of the vasculitis in Caucasians compared with black individuals has been described. The highest incidence has been reported in Scandinavia and Minnesota, mainly including a population of Northern European descent (2, 3). Studies of Italian and Israeli populations have demonstrated low frequencies (21, 22) . These ethnic differences correlate to the frequency of HLA-DR4 expressed in the different populations.
The finding that 40% of the patients were negative for B 1 *0401 and B 1 *0404/ 8 indicated that the contribution of the HLA-DR molecule in GCA is probably not related to a unique function of the DRB 1 *04 allele. We hypothesized that the disease is linked to a sequence polymorphism present in the two frequent HLA-DRB 1 *04 alleles but also expressed in non-DRB 1 *04 alleles. This hypothesis was supported by our finding that the distribution of the HLA-DRB1 genes in HLA-DRB 1 *04-patients was nonrandom. HLA (17) .
It could be argued that the HLA-DRB I locus does not represent the primary genetic factor linked to GCA. HLA haplotypes include multiple loci that are characterized by a linkage disequilibrium. No HLA-DQA or B allele can be identified that could represent a common denominator among the DR4, DR3, DRw8, and DR 13 haplotypes. In line with this finding, previous studies have failed to establish an HLA-DQ association of the disease (8) .
The comparison of the clinical findings in the DR4' and DR4-patient subsets also supported the view that the patients suffered from a similar disease entity. Especially, we could not confirm the results of a study applying metaanalysis to evaluate the role of HLA-DR4 in GCA (10) . These authors discussed that the overrepresentation of HLA-DR4 might be caused by a linkage of HLA-DR4 to PMR. In our clinically well-characterized patient cohort, symptoms of PMR were encountered as frequently in the DR4-as the DR4' patient subset. Interestingly, all patients who had developed blindness due to ischemic opticus neuritis carried the HLA-DRB1 *0401 or *0404/8 allele. In early studies of GCA, blindness was a much more frequent complication. The increased awareness of physicians probably has lead to early diagnosis and treatment before irreversible ischemic damage has evolved. However, the finding of a higher frequency of blindness in the HLA-DRB1 *0401 /4/ 8 + group may indicate that the disease progresses at a faster rate in these individuals, suggesting a potential role of these allelic variants in disease severity.
Extensive studies on yet another functional region of the HLA-DRB 1 *04 alleles have demcnstrated that a discrete portion of the HLA-DR molecule can function as the primary genetic unit underlying HLA and disease association. A set of alleles at the DRB1 locus, including HLA-DRB1 *0401, *0404/8, *0101, and * 1402, have been directly implicated in the pathogenesis of seropositive RA (23) (24) (25) (26) (27) . The polymorphism that is shared by this set of RA-associated alleles but distinct from several closely related HLA class II alleles that are not associated with RA has been mapped to a short sequence stretch of DRB 1 alleles spanning codons 67-74 (28) (29) (30) . Here, we present data that a different segment of the DRB1 gene found in B 1 *0401 and B 1 *0404/ 8 accounts for the association ofDRB 1 *04 alleles with GCA. This interpretation is supported by the underrepresentation of HLA-DR I in the GCA population, indicating that the sequence polymorphism within the HVR3 region of the gene is not relevant for the risk to develop GCA. Our finding that two different polymorphic domains of the HLA-DR molecule are linked to two separate disease entities suggests that distinct biological functions ofthe HLA-DR4 molecules are important in the pathogenesis of GCA and RA. This hypothesis is strengthened by epidemiologic data analyzing the cooccurrence of RA and GCA. In the consecutive case series of 835 patients with biopsy-proven GCA, we identified only 1 patient who had classical seropositive RA, a male who developed arthritis before GCA. There were no female patients with seropositive RA. This indicates that the cooccurrence of these two syndromes is certainly not increased, even though they share a genetic marker. The results of the case series are consistent with the paucity of reports in the literature describing GCA in patients who previously or subsequently developed RA ( 31 ). Such cases have been reported from this institution and include the one case identified in our current case series analysis. Some reports have indicated an increased mortality of RA patients, which, however, is not sufficient to explain the low cooccurrence ofboth diseases. There is no reason to believe that cases with both GCA and RA would not be recognized clinically. Rather, these data suggest the possibility that GCA patients may have an actually reduced risk to develop RA. The exact pathological mechanisms leading to seropositive RA are not understood, although a crucial role ofT lymphocytes in the disease has been established. It could be speculated that the immune abnormalities characteristic for RA prevent an abnormal immune response resulting in granulomatous vasculitic vessel wall infiltrates in GCA.
The definition of a sequence cassette linked with disease susceptibility is important for our understanding of immune functions in GCA patients. Experimental evidence has been provided demonstrating that a discrete cluster of polymorphic sites within an HLA-DR sequence can function as a functional unit on different allelic backgrounds. Defining the sequence stretch DRYF as the genetic element predisposing to GCA raises the question on the importance of this unit in immunological recognition. Modeling of the HLA-DR molecule predicts that a discrete antigen binding groove is surrounded on both sides by a-helical loops ( 18) . In this model, residues 56-86 of the : chain, including the shared epitope linked to RA, form one of the a-helical loops. In contrast, residues 28-31 of the f chain linked to GCA would contribute to the floor of the peptide binding cleft. Data derived from detailed studies ofthe functional consequences of sequence variations in murine MHC molecules indicate that the amino acid in position 28 is of crucial importance for the selective binding of antigen fragments ( 18) . Our data suggest that further analysis of the role of this residue in the immune response of GCA may provide information on the possibility that a specific disease-causative antigen might be bound by the disease-linked HLA polymorphism that initiates the vasculitic reaction in the arterial wall.
